Irachb Taraporewala News Today : Breaking News, Live Updates & Top Stories | Vimarsana

EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613

EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesIrachb taraporewalaShalomz hirschmanCenters for diseaseTrademark officeSecurities exchangePharmaceuticalholdings incHoldings incDisease controlChief medical officerUnited states patentChief executive officerSecurities actSecurities exchange act

EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil

/PRNewswire/ EOM Pharmaceutical Holdings, Inc (OTC: IMUC) ("EOM") today announced the results of its completed clinical trial in hospitalized COVID-19.

Florentino cardoso filhoShalomz hirschmanIrachb taraporewalaHoldings incBrazilian medical associationPharmaceuticalholdings incSao paoloPrincipal investigatorCasa de saude hospitalBrazilian medicalClinical scaleDisease severityChief medical officerEom pharmaceutical holdings

EOM Pharmaceutical Files For $25 Million IPO Uplisting To Nasdaq (EOM)

EOM Pharmaceutical has filed to raise $25m in an IPO, primarily for product development and to repay an outstanding note. Click here for details on the EOM IPO.

Minas geraisEndevica bioIrachb taraporewalaMoses goldbergerGilead sciencesScreen showing virus analysis software user interfaceImmunocellular therapeutics ltdGold equity groupAntibiotics in laboratoryView researchResearch scientistAcacia pharmaceuticalsCompany pipeline websiteRashbi capital groupFemale research scientistBioengineer working

EOM Pharmaceuticals Announces First Patients Dosed In R1: RESCUE Phase 1/2a Open-label Trial Evaluating EOM613 In Hospitalized COVID-19 Patients With Severe Symptoms In Brazil

EOM Pharmaceuticals Announces First Patients Dosed In R1: RESCUE Phase 1/2a Open-label Trial Evaluating EOM613 In Hospitalized COVID-19 Patients With Severe Symptoms In Brazil
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Irachb taraporewalaAraujo cardoso filhoInflamm regenBiosci biotchCenters for diseasePharmaceuticals incExecutive officerFlorentino de araujo cardoso filhoPrincipal investigatorMedical officerHospital careEmergency use authorizationSevere effectsDisease controlCoronavirus diseaseAccessed april

EOM Pharmaceuticals Announces First Patients Dosed In R1: RESCUE Phase 1/2a Open-label Trial Evaluating EOM613 In Hospitalized COVID-19 Patients With Severe Symptoms In Brazil